当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析

前沿生物-U

(688221)

  

流通市值:28.17亿  总市值:28.17亿
流通股本:3.75亿   总股本:3.75亿

前沿生物-U(688221)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-1.93亿元,每股收益-0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益114921.44万元,未分配利润-194855.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产200562.80万元,负债85641.36万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入91,643,894.3951,056,036.5124,648,130114,249,557.31
营业总成本282,018,728.06185,196,329.5486,698,546.2465,674,966.17
营业利润-193,195,084.43-160,209,310.16-55,535,627.95-327,732,439.68
利润总额-193,457,754.17-160,459,078.15-55,706,177.98-328,964,344.09
净利润-193,457,754.17-160,459,078.15-55,706,177.98-328,964,344.09
其他综合收益-9,917.824,068213.72-18,571.48
综合收益总额-193,467,671.99-160,455,010.15-55,705,964.26-328,982,915.57
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,019,445,815.41,063,499,271.461,045,696,663.751,102,785,645.43
非流动资产合计986,182,222.26993,674,051.81,037,850,073.081,037,340,850.81
资产总计2,005,628,037.662,057,173,323.262,083,546,736.832,140,126,496.24
流动负债合计476,222,583.53473,455,305.41346,795,128.75380,158,171.86
非流动负债合计380,191,038.67401,490,940.55449,775,484.89417,286,236.93
负债合计856,413,622.2874,946,245.96796,570,613.64797,444,408.79
归属于母公司股东权益合计1,149,214,415.461,182,227,077.31,286,976,123.191,342,682,087.45
股东权益合计1,149,214,415.461,182,227,077.31,286,976,123.191,342,682,087.45
负债和股东权益合计2,005,628,037.662,057,173,323.262,083,546,736.832,140,126,496.24
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计131,499,749.8488,475,130.146,789,224.65155,882,470.85
经营活动现金流出小计265,424,672.34177,666,628.3290,538,643.09423,054,270.82
经营活动产生的现金流量净额-133,924,922.5-89,191,498.22-43,749,418.44-267,171,799.97
投资活动现金流入小计2,454,419,998.831,781,984,615.63864,809,208.544,767,048,187.16
投资活动现金流出小计2,822,987,050.271,907,634,776.891,172,359,581.324,594,351,007.95
投资活动产生的现金流量净额-368,567,051.44-125,650,161.26-307,550,372.78172,697,179.21
筹资活动现金流入小计324,609,468.99281,928,311.2598,906,319.09353,799,142.64
筹资活动现金流出小计274,795,091.37218,949,984.3392,315,719.34283,505,465.95
筹资活动产生的现金流量净额49,814,377.6262,978,326.926,590,599.7570,293,676.69
汇率变动对现金及现金等价物的影响13,432.766,475.11885-50,556.47
现金及现金等价物净增加额-452,664,163.56-151,856,857.45-344,708,306.47-24,231,500.54
期末现金及现金等价物余额73,736,333.35374,543,639.46181,692,190.44526,400,496.91
最新报告期:2024-11-04
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋,胡偌碧,陈欣黎-0.60-0.49-0.322024-11-04
TOP↑